Pharmaceutical Supply of Diphenhydramine Hydrochloride

The contract entails the supply and delivery of 3,000 pounds of Diphenhydramine Hydrochloride, identified by NSN 6505001320294, to meet Department of Defense medical substitution requirements. The work involves formulation, repackaging, or manufacturing activities to ensure compliance with military standards for pharmaceuticals, and is structured as a subcontract under the Defense Logistics Agency. The product is a critical pharmaceutical asset intended for use in military medical systems, and its production must adhere strictly to federal and DoD regulatory protocols to guarantee safety, efficacy, and consistency. The NAICS code 325412 indicates the nature of the work as pharmaceutical preparation manufacturing, underscoring the technical and quality control demands of the task. The contract was posted on July 14, 2026, and is linked to the award SPE2DX25D9900 with delivery order SPE2DP26F7659, reflecting a formal procurement pathway under DLA's medical logistics framework. While the solicitation number is not provided, the contract's structure implies it was sourced through a competitive or pre-vetted vendor network aligned with DoD medical supply chain priorities. The place of performance and point of contact details are unspecified, suggesting centralized management by the DLA with logistics execution potentially distributed across approved manufacturing or repackaging facilities. Delivery timelines and quality assurance protocols are governed by military-specific pharmaceutical directives, requiring rigorous documentation and traceability throughout the supply chain.